FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization. On June 11, 2024, FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company focused on creating innovative biotech solutions, announced an exclusive option agreement with the University of Southern California (USC). This agreement grants FSD Pharma ...
FSD Pharma Inc股票讨论区
On June 11, 2024, FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company focused on creating innovative biotech solutions, announced an exclusive option agreement with the University of Southern California (USC). This agreement grants FSD Pharma ...
暂无评论